−
−
because of the presence of new chelating sites: (COO , COO )
oroacetic acid (TFA) (25 ml) and left at room temperature,
protected from moisture, with occasional stirring for 1 h. The
solution was then concentrated and diethyl ether was added.
The mixture was cooled. The ether was decanted off and the oil
obtained was dried. A solid foam was obtained in quantitative
yield and used in the next step without further purification.
−
in GlyAsp and (NH
2
, COO ) in AspGly. Although these sites
are more efficient for V O binding, the extent of amide
deprotonation/coordination is hardly enhanced as compared
IV 2+
6
with the Gly-type dipeptides.
In this work the pseudo di- and tri-peptides analogues of
salicylic acid, containing aspartic acid in the C terminal position:
Sal-L-Asp 1 (L ) and SalGly-L-Asp 2 (L ) were synthesized and
NMR-DMSOd6 2.78–2.82 (2H, m, aCH Asp); 3.63 (3H, s,
2
1
2
OCH
3
); 3.61 (5H, s + overlapped, CH
2
Gly + OCH
3
); 4.71 (1H,
); 8.95 (1H, d J
IV 2+
+
their V O -binding abilities were studied by means of pH-
apq J 7.2 Hz, aCHAsp); 8.09 (3H, br s, NH
3
potentiometric and spectroscopic techniques.
8 Hz, NH-Asp).
SalGly-L-Asp(OMe)OMe. Salicylic acid (0.69 g, 5 mmol)
Experimental
was dissolved in ethyl acetate (20 ml) and the solution was
◦
Preparation of Sal-L-Asp 1
cooled to 0 C. DCC (1.08 g, 5.2 mmol), compound TFA·Gly-L-
Asp(OMe)OMe (1.66 g, 5 mmol) and triethylamine (0.9 ml,
5 mmol) were added successively. The reaction mixture was
stirred overnight at room temperature. The insolubles were
filtered off and the solvents were removed under reduced
pressure. The residue was taken up in a minimum amount of
Synthesis of L-Asp(OMe)OMe. Thionyl chloride (25 ml)
◦
was added dropwise to stirred and cooled (−10 C) methanol
(
100 ml), followed by the addition of L-Asp (6.66 g, 50 mmol).
◦
The temperature of the solution was then increased to 40 C for
2
h. The solvent was removed next and the oil obtained, after
◦
acetone and left at 0 C for 4 h. The precipitated solid was
crystallization from methanol–diethyl ether, afforded the pure
compound (7.8 g, 79%, mp 115–116 C).
NMR-DMSOd6 3.00–3.03 (2H, m, CH
◦
filtered off (DCHU) and the solution was concentrated. The oil
obtained resisted crystallization (1.091 g, 67%).
NMR-DMSOd6 2.70 and 2.80 (2H, dd J 1.5 and 6.0 Hz,
2
); 3.74 and 3.64 (6H,
+
2
s, 2 × OCH ); 4.32 (1H, t J 5.7 Hz, CH); 8.79 (3H, br s, NH
3
3
).
aCH
5.4 Hz, CH
2
Asp); 3.60 and 3.62 (6H, 2s, 2 × OCH
3
); 3.94 (2H, d J
Gly); 4.70 (1H, apq J 6.0 Hz, aCHAsp); 6.90–6.92
Sal-L-Asp(OMe)OMe. Salicylic acid (2.76 g, 20 mmol) was
2
dissolved in ethyl acetate (80 ml) and the solution was cooled
to 0 C. Dicyclohexylcarbodiimide (DCC) (4.3 g, 21 mmol), L-
Asp(OMe)OMe (3.95 g, 20 mmol) and triethylamine (3.6 ml,
(2H, m, 3-H and 5-H); 7.39 (1H, tap J 8.1 Hz, 4-H) 7.86 (1H,
dd J 0.9 and 8.4 Hz, 6-H); 8.54 (1H, d J 8.1 Hz, NHAsp); 9.08
(1H, t J 6.0 Hz, NHGly); 12.20 (1H, s, Ar-OH).
◦
2
0 mmol) were added successively. The reaction mixture was
stirred overnight at room temperature. The insolubles were then
filtered off and the solution was washed in turn with 5% citric
acid, water, 5% NaHCO
SalGly-L-Asp. SalGly-L-Asp(OMe)OMe
(1.090
g,
3.22 mmol) was dissolved in methanol (10 ml) and an
aqueous solution of 1 M NaOH was added (9.69 ml). The
mixture was stirred at room temperature for 4 h, and 1 M HCl
(3.3 ml) was then added. The methanol was removed under
reduced pressure and the solution obtained was cooled in an
ice-bath and acidified with 1 M HCl (6.4 ml) under vigorous
stirring. This aqueous solution was extracted three times with
ethyl acetate; the organic layers were collected, dried over
magnesium sulfate and filtered and the solvent was removed.
A solid foam was obtained (585 mg, 58%). An attempt of
crystallization from a mixture of methanol, diethyl ether and
3
and water. After drying over MgSO ,
4
the solution was concentrated. The residue was taken up in
◦
a minimum amount of acetone and left at ∼0 C for 4 h.
The precipitated solid was filtered off and the solution was
concentrated. The oil obtained proved resistant to crystallization
(
4.48 g, 79%).
NMR-DMSOd6 2.90–3.20 (2H, m, CH Asp); 3.69–3.78 (1H,
2
m, aCHAsp); 6.91 (2H, apparent t J 7.8 Hz); 7.40 (1H, apparent
t J 8.0 Hz) 7.86 (1H, dd J 1.2 and 8.0 Hz,); 8.90 (1H, d J 8.1 Hz,
NHAsp); 12.40 (1H, br s, OH).
◦
petroleum spirit afforded a white solid, melting at 105–107 C.
NMR-DMSOd6 2.60 and 2.70 (2H, dd J 1.5 and 6.0 Hz,
Sal-L-Asp 1. Sal-L-Asp(OMe)OMe (4.47 g, 15.9 mmol) was
dissolved in methanol (30 ml) and 1 M NaOH (50 ml, 50 mmol)
was added. The mixture was stirred at room temperature for
bCH
.0 Hz, aCHAsp); 6.86–6.92 (2H, m, 3-H and 5-H); 7.39 (1H,
tap J 8.1 Hz, 4-H) 7.86 (1H, dd J 0.9 and 8.4 Hz, 6-H); 8.37
2
Asp); 3.94 (2H, d J 5.7 Hz, CH Gly); 4.56 (1H, apq J
2
6
2
h, and 1 M HCl (16 ml, 16 mmol) was added. The methanol
was removed at reduced pressure and the solution thus obtained
was cooled in an ice bath and acidified with 1 M HCl (34 ml)
under vigorous stirring. The white solid that precipitated out
(
(
1H, d J 7.8 Hz, NHAsp); 9.06 (1H, t J 5.7 Hz, NHGly); 12.20
1H, s, Ar–OH): 12.60 (2H, br s, CO H).
Anal. Calcd. for C14
+ 1/2 C
0.85, H 5.08, N 7.91. Found: C 50.2, H 5.4, N 7.9.
2
H
18
N
2
O
5
4
H
8
O (ethyl acetate): C
2
was filtered off, washed with water and dried (1.2 g, 30%, mp
5
◦
171–172 C).
NMR-DMSOd6 2.84–2.81(2H, m, bCH2Asp); 4.75 (1H, ap-
parent q J 8.1 Hz, aCHAsp), 6.91 (2H, apparent t J 7.2 Hz);
pH-Potentiometric measurements
7
9
.39 (1H, td J 1.8 and 8.0 Hz), 7.88 (1H, dd J 1.8 and 8.2 Hz);
.13 (1H, d J 8.1 Hz, NH); 12.85 (1H, s, OH); 12.60 (2H, br s,
The protonation constants of Sal-L-Asp and SalGly-L-Asp
and the stability constants of their V O complexes were
IV 2+
OH).
Found: C, 52.4; H, 4.6; N, 5.5. Calcd. for C11
H, 4.65; N, 5.18%.
◦
3
determined at 25 C by pH-metric titration of 10 cm sam-
ples. The pHs were measured with an Orion 720A pH-meter
equipped with an Metrohm 6.0234.100 combined glass electrode
H
11
6
O N: C, 52.18;
7
calibrated for hydrogen ion concentration. The ligand concen-
−
3
Preparation of SalGly-L-Asp 2
trations were 0.0020 and 0.0040 mol dm and the ligand to
metal molar ratios were 4 : 4, 4 : 2, 4 : 1, 2 : 2 and 2 : 1. Titrations
were performed with KOH solution of known concentration
Boc·Gly-L-Asp(OMe)OMe. This was prepared by the DCC
method on a 10 mmol scale. The chromatographically pure oil
obtained (2.75 g, 86%) resisted crystallization.
−
3
(
ca. 0.2 mol dm ) under a purified argon atmosphere, to
avoid interference from oxygen and carbon dioxide in the
air. The pH range studied was normally from 2 to 10 unless
extensive hydrolysis or a very slow equilibrium was detected.
The reproducibility of titration points included in the evaluation
NMR-DMSOd6 1.36 (9H, s, Boc); 2.72–2.77 (2H, m,
CH
2
Asp); 3.50 (2H, d J 6 Hz, CH
2
Gly); 3.61 and 3.59 (3 +
3
H, s, 2 × OCH
3
); 4.66 (1H, apq J 7.8 Hz, aCHAsp); 6.97 (1H,
t J 6 Hz, NHGly); 8.23 (1H, d J 8 Hz, NH-Asp).
was within 0.005 pH units in the whole pH range. A pK
w
◦
value
TFA·Gly-L-Asp(OMe)OMe. The protected peptide Boc·Gly-
of 13.76 was determined and used for the titrations at 25 C and
I = 0.20 mol dm− KCl.
3
L-Asp(OMe)OMe (5 mmol, 1.598 g) was treated with triflu-
D a l t o n T r a n s . , 2 0 0 5 , 3 0 7 2 – 3 0 7 8
3 0 7 3